福井大学医学部

感染症学講座

研究業績

2021年度

1. Itoh KSakamaki I, Hirota T, Iwasaki H. Evaluation of minocycline combined with favipiravir therapy in coronavirus disease 2019 patients: A case-series study. J Infect Chemother. 2022 Jan;28(1):124-127. 

2. Kawasuji H, Morinaga Y, Tani H, Yoshida Y, Taekgoshi Y, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Fukui Y, Kimura M, Yamada H, Sakamaki I, Yamamoto Y. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is storonglay associated with disease severity and mortality in patients with COVID-19. J Med Virol. 2022 Jan;94(1):147-153.

3. Sakamaki I, Fukushi M, Ohashi W, Tanaka Y, Itoh K, Tomihara K, Yamamoto Y, Iwasaki H. Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells. Sci Rep. 2021 Dec 17;11(1):24154. 

4. Kawasuji H, Morinaga Y, Tani H, Kimura M, Yamada H, Yoshida Y, Takegoshi Y, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Kawago K, Fukui Y, Sakamaki I, Yamamoto Y. Delayed neutralizin antibody response in the acute phase correlates with severe progression of COVID-19. Sci Rep. 2021 Aug 16;11(1):16535.

5. Fukui Y, Kawasuji H, Taekgoshi Y, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Kawago K, Sakamaki I, Morinaga Y, Yamamoto Y. Investigation of nasopharyngeal viral load at discharge in patients with COVID-19. J Infect Chemother. 2021 Jul;27(7):1122-1125.

6. Ueno A, Kawasuji H, Miyajima Y, Fukui Y, Sakamaki I, Saito M, Yamashiro S, Morinaga Y, Oishi K, Yamamoto Y. Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population. J Infect Chemother. 2021 Jul;27(7):1119-1121.

7. Ueno A, Sakamaki I, Yamamoto Y. An elderly man with a locked jaw. Eur J Intern Med. 2021 Jun 10:S0953-6205(21)00166-7.

8. Murai Y, Kawasuji H, Takegoshi Y, Kaneda M, Kimoto K, Ueno A, Miyajima Y, Kawago K, Fukui Y, Ogami C, Sakamaki I, Tsuji Y, Morinaga Y, Yamamoto Y. A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test. Int J Infect Dis. 2021 May;106:33-35.

9. Kawasuji H, Tsuji Y, Ogami C, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Fukui Y, Sakamaki I, Yamamoto Y. Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients. Antibiotics (Basel). 2021 Apr 26;10(5):496.

10. Kutsuna S, Asai Y, Yamamoto K, Shirano M, Konishi K, Asaoka T, Yamato M, Katsuragi Y, Yamamoto Y, Sahara T, Tamiya A, Nakamura-Uchiyama F, Sakamoto N, Kosaka A, Washino T, Hase R, Mito H, Kurita T, Shinohara K, Shimizu T, Kodama F, Nagasaka A, Ogawa T, Kasahara K, Yoshimura Y, Tachikawa N, Yokota K, Yuka Murai NS, Sakamaki I, Hasegawa C, Yoshimi Y, Toyoda K, Mitsuhashi T, Ohmagari N. Epidemiological trends of imported infectious diseases in Japan: Analysis of imported 2-year infectious disease registry data. J Infect Chemother. 2021 Apr;27(4):632-638.

 

感染症学講座研究室